Mobile menu

Teresa Johnson, MS, PhD

Teresa Johnson

Teresa Johnson, MS, PhD

Discipline Chair for Microbiology and Immunology
Virginia Campus

Academic Office 232; Lab Office CMMID 112; Labs CMMID Rooms 1 and 2

540-231-5747 lab
trjohnson [at]
Curriculum Vitae: 


2001 National Institutes of Health Post-doctoral Fellowship
2000 Vanderbilt University School of Medicine Post-doctoral Fellowship
1999 Vanderbilt University School of Medicine PhD - Microbiology and Immunology
1990 Virginia Commonwealth University, Medical College of Virginia MS - Microbiology and Immunology
1985 Liberty University BS - Mathematics

Awards and Honors

  • 9th International Respiratory Syncytial Virus Symposium, November 2014, Travel Grant
  • Patent: US-20100247621 A1. Graham BS, Johnson, TR. Codon Modified Immunogenic Compositions and Methods of Use.
  • Patent pending: WO2009092113. Graham BS, Buck CB, Johnson TR, Kines RC, Nicewonger JD, Roberts JN, Schiller JT Use Of Hpv Virus-like Particles To Deliver Gene-based Vaccines.

Current Professional Organizations

  • Member, American Association of Immunologists
  • Member, American Society for Microbiology
  • Member, Federation of Clinical Immunology Societies
  • Member, International Cytokine and Interferon Society
  • Member, Society for Leukocyte Biology

Current Research Projects

  • Development of a nosocomial bacterial vaccine
  • Development of a point-of-care diagnostic kit for bacterial and viral pneumonia
  • Effect of boron on UV-induced skin cancer
  • Evaluation of respiratory syncytial virus pathogenesis
  • Isolation of antiviral and hemostatic factors from a naturally-occurring substance for treatment of viral infections and wounds of the dermis


Year Published Faculty Citation PMID

Kines RC, Zarnitsyn V, Johnson TR, et. al. Vaccination with human papillomavirus pseudovirus-encapsidated plasmids targeted to skin using microneedles. PLoS One. 2015 Mar 18;10(3):e0120797.


Prater R, Johnson TR, Stoner AM, Cannon MD, Sriranganathan N. Animals, Humans and the Environment in the Epidemiology of Chikungunya Virus [case study]. AAVMC/APTR. 2015:


Johnson TR, Rangel D, Graham BS, Brough DE, and Gall JG. Genetic vaccine for respiratory syncytial virus provides protection without disease potentiation. Molecular Therapy. 2014 Jan; 22(1):196-205. PMID: 23752342.


Hillyer P, Raviv N, Gold DM, Dougherty D, Liu J, Johnson TR, Graham BS, Rabin RL. Subtypes of type I IFN enhance cytokine expression by suboptimally stimulated CD4+ T cells. European Journal of Immunology. 2013 Dec; 43(12):3197-208.


Quinn KM, Yamamoto A, Costa A, Darrah PA, R. Lindsay RW, Hegde ST, Johnson TR, Flynn BJ, Lore K, Seder RA. Coadministration polyinosinic:polycytidylic acid and immunostimulatory complexes modifies antigen processing in dendritic cell subsets and enhances HIV gag-specific T cell immunity. Journal of Immunology. 2013 Nov 15: 191(10):5085-96. PMID: 24089189.